ArticleBMC cardiovascular disorders2026
Systolic blood pressure strata and acute kidney injury risk in heart failure: a retrospective cohort study.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
BACKGROUND AND
objectiveIn patients with acute heart failure (HF), both hypotension and hypertension may compromise renal perfusion, yet the association between systolic blood pressure (SBP) and acute kidney injury (AKI) risk is controversial and poorly quantified. This study aimed to define this relationship.
methodsIn this retrospective cohort analysis of 19,604 HF patients from the MIMIC-IV database, individuals were categorized into three SBP strata based on their mean SBP during the first 24 hours of intensive care unit admission: strict (<110 mmHg), standard (110-139 mmHg), and lenient (≥140 mmHg). We employed multivariable logistic regression, propensity score weighting, and restricted cubic spline (RCS) analysis to evaluate associations. To further address confounding, we incorporated standardized ICU severity scores (OASIS, SAPS II, APACHE III) into the models. Sensitivity analyses were performed using alternative SBP cutoffs and in a subcohort with available BNP measurements. A predictive model was developed and internally validated via bootstrapping.
resultsThe overall incidence of AKI was 36.6%. After multivariable adjustment, compared with the lenient SBP stratum (≥140 mmHg), both strict (<110 mmHg; aOR 0.74, 95% CI 0.67-0.82) and standard (110-139 mmHg; aOR 0.77, 95% CI 0.69-0.86) SBP strata were associated with significantly lower odds of AKI. These associations remained robust after adjustment for OASIS (strict: aOR 0.71, 0.64-0.79; standard: aOR 0.75, 0.68-0.84), SAPS II (strict: aOR 0.67, 0.60-0.75; standard: aOR 0.75, 0.67-0.83), and APACHE III (strict: aOR 0.69, 0.62-0.77; standard: aOR 0.76, 0.68-0.85). RCS analysis revealed a significant non-linear relationship, with the lowest predicted AKI risk at an SBP of approximately 120 mmHg. Key independent risk factors included chronic kidney disease (aOR 2.64) and elevated 48-hour creatinine ratio (aOR 2.07 per unit). The full prediction model demonstrated moderate discrimination (area under the curve [AUC] = 0.726, 95% CI: 0.718-0.733) but significant calibration issues (Hosmer-Lemeshow P < 0.001). Internal validation yielded an optimism-corrected AUC of 0.726. Notably, in sensitivity analyses focusing on severe AKI, both standard and lenient strategies were associated with significantly lower risk compared to strict control. The simplified model (6 variables) showed poor calibration (Hosmer-Lemeshow P < 0.001, Brier 0.205) but provided positive net benefit in decision curve analysis across thresholds 0-0.7; however, its poor calibration limits clinical application, and the net benefit estimates should be interpreted with caution.
conclusionCompared with the lenient SBP stratum, both strict and standard SBP strata were associated with significantly lower odds of overall acute kidney injury in heart failure patients. However, the relationship is non-linear, with the lowest predicted risk observed at approximately 120 mmHg. These findings suggest that an observed SBP of approximately 120 mmHg was associated with the lowest risk of AKI in this population, warranting prospective validation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.